Top 10 Diabetes Care Technologies, Devices and Therapeutics Markets - Growth, Global Share, Industry Overview, Analysis, Trends Opportunities and Forecast 2012 - 2020 Multiple Sclerosis Market in the US 2015-2019 Growth, Global Share, Industry Overview, Analysis, Trends Opportunities and Forecast
Description Report Overview About Multiple Sclerosis Multiple sclerosis is a chronic, inflammatory medical condition, which results in demyelination, axonal transection, and neurodegeneration of the nerve cells of the brain and spinal cord. The immune system of the body targets the neurons within the CNS and damages the myelin sheath. It is a potentially debilitating disease, causing disruption in the communication and coordination functions of the body. The symptoms of multiple sclerosis differ widely, subject to the extent of damage and the number of neurons affected. Some of the symptoms observed are fatigue, numbness, spasticity, bladder dysfunction, cognitive changes, emotional changes, and depression. An individual with severe form of the disease can experience speech and movement problems. Multiple sclerosis can be broadly classified into four types: RRMS, SPMS, PPMS, and PRMS. The multiple sclerosis market in the US to grow at a CAGR of 3.8% over the period 2014-2019. Read more details at: http://www.bigmarketresearch.com/multiple-sclerosis-in-the-us-2015-2019-market
Key Benefits Summery Covered in this Report The multiple sclerosis market, report covers the present scenario and the growth prospects of the multiple sclerosis market in the US for the period 2015-2019. To calculate the market size, the report considers revenue generated from sales of various drugs used in the treatment of multiple sclerosis. On the basis of route of administration of the drugs, the market is grouped into the following categories: • Oral • Parenteral On the basis of type of molecule of the drugs, the market is grouped into the following categories: • Small Molecules • Biologics The report also presents the vendor landscape and a corresponding detailed analysis of the top vendors and competitive performances of their product portfolios in the market. In addition, it discusses the major drivers that influence the growth of the market.
Key Audiences Key Vendors • Bayer AG • Biogen • Merck Serono • Novartis AG • Teva Pharmaceutical Industries Ltd. Other Prominent Vendors • AB Science • Abbvie • Acorda Therapeutics • Active Biotech • Artielle • Astellas • AstraZeneca • Canbex • F. Hoffmann-La Roche • GeNeuro • GlaxoSmithKline
Table Of Contents Company Profile Market Driver • Unmet Medical Needs. • For a full, detailed list, view our report. Market Challenge • Unknown Disease Etiology. • For a full, detailed list, view our report. Market Trend • Introduction of Disease-modifying Drugs. • For a full, detailed list, view our report. Enquire about report:http://www.bigmarketresearch.com/report-enquiry/250865
Get Full Information At: http://www.bigmarketresearch.com/multiple-sclerosis-in-the-us-2015-2019-market